Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL., Lancellotti P., Rodriguez Muñoz D., Aboyans V., Asteggiano R., Galderisi M., Habib G., Lenihan DJ., Lip GYH., Lyon AR., Lopez Fernandez T., Mohty D., Piepoli MF., Tamargo J., Torbicki A., Suter TM., ESC Scientific Document Group .

More information

DOI

10.1093/eurheartj/ehw211

Type

Journal article

Publication Date

21/09/2016

Volume

37

Pages

2768 - 2801

Total pages

33

Keywords

European Society of Cardiology, arrhythmias, cancer therapy, cardio-oncology, cardiotoxicity, chemotherapy, early detection, ischaemia, myocardial dysfunction, surveillance, Advisory Committees, Antineoplastic Agents, Cancer Survivors, Cardiology, Cardiotoxicity, Humans, Immunotherapy, Neoplasms, Radiotherapy, Societies, Medical, Vascular Endothelial Growth Factor A